Artivion | CRY




Peers Price Chg Day Year Date
Terumo 2,182.00 17.00 0.79% -21.17% Apr/03
Abbott 102.87 0.49 0.48% -21.85% Apr/02
AngioDynamics 10.31 -1.63 -13.65% 4.99% Apr/02
Accuray 0.42 0.03 6.74% -75.44% Apr/02
AtriCure 29.07 0.76 2.68% -11.70% Apr/02
Baxter International 16.68 -0.10 -0.60% -46.79% Apr/02
Becton, Dickinson and Co. 154.51 -1.83 -1.17% -30.27% Apr/02
Boston Scientific 62.82 0.82 1.32% -36.22% Apr/02
Artivion 34.17 0.01 0.03% 41.55% Apr/02
Edwards Lifesciences 81.05 -0.21 -0.26% 11.06% Apr/02

Indexes Price Day Year Date
US2000 2530 17.67 0.70% 32.42% Apr/02

Artivion Inc traded at $34.17 this Thursday April 2nd, increasing $0.01 or 0.03 percent since the previous trading session. Looking back, over the last four weeks, Artivion gained 11.52 percent. Over the last 12 months, its price rose by 41.55 percent. Looking ahead, we forecast Artivion Inc to be priced at 33.14 by the end of this quarter and at 30.24 in one year, according to Trading Economics global macro models projections and analysts expectations.

CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.